Monitoring Selected National HIV Prevention and Care Objectives By Using HIV Surveillance Data United States and 6 Dependent Areas, 2020

HIV Surveillance Report - Supplemental Report banner

Monitoring Selected National HIV Prevention and Care Objectives By Using HIV Surveillance Data United States and 6 Dependent Areas, 2020

Key Findings

The Selected National HIV Prevention and Care Outcomes are indicators used to monitor progress toward U.S. national goals outlined in Healthy People 2030, the National HIV/AIDS Strategy, and the Ending the HIV Epidemic in the U.S. (EHE) initiative. Data are presented for diagnoses of HIV infection reported to CDC through December 2021. 

COVID-19 Pandemic Impact 

Data for the year 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state and local jurisdictions.
Differences in Linkage to Care Among People with HIV Diagnosed in 2020 by Race/Ethnicity*
More than 80 percent of people overall with HIV diagnosed in 2020 were linked to care within one month of diagnosis
Percentage of people linked to care by race/ethnicity.

Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic. For more information, view the report commentary. Data from 45 states and the District of Columbia with complete reporting of laboratory data to CDC.
* Among people aged 13 and older.
Hispanic/Latino people can be of any race.
Source: CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2020. HIV Surveillance Supplemental Report, 2022, 27(3).

Download or share:

HIV Care Among People with Diagnosed HIV in 45 States and the District of Columbia*
This chart shows the proportion of people who received care, were retained in care, and were virally suppressed.

Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic. For more information, view the report commentary. Data from 45 states and the District of Columbia with complete reporting of laboratory data to CDC.
* Among people aged 13 and older.
† At least 1 viral load or CD4 test.
‡ Had 2 viral load or CD4 tests at least 3 months apart in a year.
** Based on most recent viral load test.
Source: CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2020. HIV Surveillance Supplemental Report, 2022, 27(3).

Download or share:

Differences in HIV Care Among People with Diagnosed HIV by Race/Ethnicity*
Differences in HIV Care Among People with Diagnosed HIV by Race/Ethnicity

Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic. For more information, view the report commentary. Data from 45 states and the District of Columbia with complete reporting of laboratory data to CDC.
* Among people aged 13 and older.
† At least 1 viral load or CD4 test.
‡ Had 2 viral load or CD4 tests at least 3 months apart in a year.
** Based on most recent viral load test.
†† Hispanic/Latino people can be of any race.
Source: CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2020. HIV Surveillance Supplemental Report, 2022, 27(3).

Download or share:

Differences in PrEP Coverage in the United States and Puerto Rico by Race/Ethnicity*
Of the 1.2 million people in the US and Puerto Rico who could benefit from PrEP, only 25% were prescribed PrEP in 2020.
Differences in PrEP Coverage in the United States and Puerto Rico by Race/Ethnicity

Abbreviation: PrEP = Pre-exposure prophylaxis
Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic. For more information, view the report commentary. Data from 45 states and the District of Columbia with complete reporting of laboratory data to CDC.
commentary.
* Among people aged 16 and older.
† Hispanic/Latino people can be of any race.
‡ Includes American Indian/Alaska Native, Asian, Native Hawaiian and other Pacific Islander, and multiracial people.
Source: CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2020. HIV Surveillance Supplemental Report, 2022, 27(3).

Download or share:

This issue of the HIV Surveillance Supplemental Report is published by the Division of HIV Prevention (DHP), National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta, Georgia.

Data are presented for diagnoses of HIV infection reported to CDC through December 2021.

The HIV Surveillance Supplemental Report is not copyrighted and may be used and copied without permission. Citation of the source is, however, appreciated.

Suggested Citation

Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2020. HIV Surveillance Supplemental Report 2022;27(No. 3). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published May 2022. Accessed [date].

On the Web: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html

Confidential Information, Referrals, and Educational Material on HIV Infection

CDC-INFO
1-800-232-4636 (in English, en Español)
1-888-232-6348 (TTY)
http://wwwn.cdc.gov/dcs/ContactUs/Form

Publication Credit

Publication of this report was made possible by the contributions of the state and territorial health departments and the HIV surveillance programs that provided surveillance data to CDC.

This report was prepared by the following staff and contractors of the Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC: Shacara Johnson Lyons, Anna Satcher Johnson, Xiaohong Hu, Pei Hou, Britany Helton, Faith Elenwa, Zanetta Gant, André F. Dailey, Dawn Smith, Ya-lin Huang, Weiming Zhu, Lei Yu, Ishwarya Ravichandran, Seidu Inusah, Norma Harris, Anne Peruski, Tonya Joyner (editing), Michael Friend (editing and desktop publishing), Azfar Siddiqi (science review), and Chief of the HIV Surveillance Branch, Angela L. Hernandez.

Other Acknowledgments

The following are acknowledged for their contributions to the report (including graphics) and report website: Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC: Amanda Okello, Shruthi Nagaraju, Tanja Walker, Donna McCree, Krishna Kota; the Prevention Communication Branch: Nitesh Parmar, Fred Noble, Scott Outman (Content and Infrastructure Team); and the Division of Communication Services: Mikaelyn Benson, Deirdre Launt, Meredith Newlove, Cesar Rivera (Design Team).